ATG4D and cancer: Furthermore, after inhibiting the expression of ATG4D by siRNA in cells, mitochondrial membrane potential (Figure 5F) and cell apoptosis (Figure 5G) were all decreased, no matter whether Rosiglitazone or T0070907 was used to treat cancer cells or not.